These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35649647)

  • 1. Tau PET Imaging in Neurodegenerative Disorders.
    Groot C; Villeneuve S; Smith R; Hansson O; Ossenkoppele R
    J Nucl Med; 2022 Jun; 63(Suppl 1):20S-26S. PubMed ID: 35649647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
    Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
    JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
    Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head comparison of tau positron emission tomography tracers [
    Smith R; Schöll M; Leuzy A; Jögi J; Ohlsson T; Strandberg O; Hansson O
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):342-354. PubMed ID: 31612245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
    Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [
    Young CB; Landau SM; Harrison TM; Poston KL; Mormino EC;
    Neuroimage; 2021 Nov; 243():118553. PubMed ID: 34487825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [
    Tissot C; Servaes S; Lussier FZ; Ferrari-Souza JP; Therriault J; Ferreira PCL; Bezgin G; Bellaver B; Leffa DT; Mathotaarachchi SS; Chamoun M; Stevenson J; Rahmouni N; Kang MS; Pallen V; Margherita-Poltronetti N; Wang YT; Fernandez-Arias J; Benedet AL; Zimmer ER; Soucy JP; Tudorascu DL; Cohen AD; Sharp M; Gauthier S; Massarweh G; Lopresti B; Klunk WE; Baker SL; Villemagne VL; Rosa-Neto P; Pascoal TA
    J Nucl Med; 2023 Mar; 64(3):452-459. PubMed ID: 36396455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
    Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
    Ageing Res Rev; 2017 Jul; 36():50-63. PubMed ID: 28315409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compensating for choroid plexus based off-target signal in the hippocampus using
    Pawlik D; Leuzy A; Strandberg O; Smith R
    Neuroimage; 2020 Nov; 221():117193. PubMed ID: 32711062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in off-target binding using tau positron emission tomography.
    Smith R; Strandberg O; Leuzy A; Betthauser TJ; Johnson SC; Pereira JB; Hansson O
    Neuroimage Clin; 2021; 31():102708. PubMed ID: 34091353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
    Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA
    J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter comparison of [
    Leuzy A; Pascoal TA; Strandberg O; Insel P; Smith R; Mattsson-Carlgren N; Benedet AL; Cho H; Lyoo CH; La Joie R; Rabinovici GD; Ossenkoppele R; Rosa-Neto P; Hansson O
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2295-2305. PubMed ID: 34041562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial volume correction in longitudinal tau PET studies: is it really needed?
    Costoya-Sánchez A; Moscoso A; Sobrino T; Ruibal Á; Grothe MJ; Schöll M; Silva-Rodríguez J; Aguiar P;
    Neuroimage; 2024 Apr; 289():120537. PubMed ID: 38367651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-head comparison of [
    Aguero C; Dhaynaut M; Amaral AC; Moon SH; Neelamegam R; Scapellato M; Carazo-Casas C; Kumar S; El Fakhri G; Johnson K; Frosch MP; Normandin MD; Gómez-Isla T
    Acta Neuropathol; 2024 Jan; 147(1):25. PubMed ID: 38280071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of a [
    Coomans EM; de Koning LA; Rikken RM; Verfaillie SCJ; Visser D; den Braber A; Tomassen J; van de Beek M; Collij LE; Lemstra AW; Windhorst AD; Barkhof F; Golla SSV; Visser PJ; Scheltens P; van der Flier WM; Ossenkoppele R; van Berckel BNM; van de Giessen E
    Neurology; 2023 Nov; 101(19):e1850-e1862. PubMed ID: 37748892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351.
    Oh M; Oh SJ; Lee SJ; Oh JS; Roh JH; Chung SJ; Lee JH; Lee CS; Kim JS
    Clin Nucl Med; 2020 Nov; 45(11):841-847. PubMed ID: 32910050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.